CRON (Cronos Group) ROCE %: -0.51% (As of Mar. 2026)


CRON Cronos Group Inc CRON
86 GF Score
Price $2.82
GF Value $3.49
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Cronos Group ROCE %?

Cronos Group CRON +3.31% 86 ROCE % is -0.51% as of Mar. 2026. GuruFocus rates CRON with a GF Score™ of 86/100 and a GF Value™ of $3.49 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cronos Group's annualized ROCE % for the quarter that ended in Mar. 2026 was -0.51%.

Cronos Group  (NAS:CRON) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cronos Group ROCE % Related Terms

Cronos Group ROCE % Historical Data

* Premium members only.

The historical data trend for Cronos Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cronos Group ROCE % Chart

Cronos Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.81 -8.39 -7.12 -5.38 -1.72

Cronos Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.26 -1.61 -1.77 -2.24 -0.51
CRON
86GF Score
Cronos Group Inc CRON
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cronos Group ROCE % Calculation

Cronos Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-19.497/( ( (1166.312 - 49.7) + (1197.14 - 48.187) )/ 2 )
=-19.497/( (1116.612+1148.953)/ 2 )
=-19.497/1132.7825
=-1.72 %

Cronos Group's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-5.82/( ( (1197.14 - 48.187) + (1172.109 - 42.42) )/ 2 )
=-5.82/( ( 1148.953 + 1129.689 )/ 2 )
=-5.82/1139.321
=-0.51 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -0.51% mean?
Cronos Group (CRON) has a ROCE % of -0.51% as of Mar. 2026.
Is Cronos Group's ROCE % too high?
Cronos Group's current ROCE % is -0.51%. Overall, Cronos Group has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cronos Group's ROCE % compare to ZTS?
Cronos Group's ROCE % of -0.51% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cronos Group's current ROCE % is -0.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cronos Group stock overvalued right now?
Based on GuruFocus' analysis, Cronos Group (CRON) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.49, compared to a current price of $2.82 — trading 19.2% below its estimated fair value. The current ROCE % is -0.51%. Cronos Group's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Cronos Group (CRON), the current ROCE % is -0.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cronos Group (CRON) Overvalued in 2026?

Based on GuruFocus' analysis, Cronos Group stock appears to be undervalued. The current stock price of $2.82 is trading 19.2% below its estimated GF Value™ of $3.49. GuruFocus considers Cronos Group to be Modestly Undervalued.

Key valuation signals for CRON:

  • ROCE %: -0.51%
  • GF Value™: $3.49 vs. price of $2.82 (19.2% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the CRON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cronos Group Business Description

Other Exchanges 7CI:GermanyCRON:Canada
Address 4491 Concession Rd 12, Stayner, ON, CAN, L0M 1S0
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
86GF Score

Get the complete analysis for CRON

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.82
Price
$3.49
GF Value